Print this page

Organization follows strategy

Werfen’s strategy consists in a high level of specialization in selected IVD segments in which we are able to provide best-in-class solutions for our partners and Customers around the world.

Thanks to this, we have been able to achieve leadership positions in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity.

To continue leveraging and further increase our top positions in these fields, Werfen is constantly investing in delivering new innovative solutions, leading the industry, and further fulfilling worldwide customers’ needs and expectations.

With this strategy in mind, at EEMEAI we are very pleased to inform you about the new Customer Support organizational structure being effective on March 1st, 2022.

The new structure, intended to continue providing excellent 2nd Level of Service, Application and IT support to your respective organizations, is divided into three main groups: IT Support, Acute Care Diagnostics Support and Lab Support which will include both Lab Hemostasis and Autoimmunity.    

Furthermore, within Lab Support we have created a new position in charge of coordinating any future HemoCell and HemoHub installation in our respective territories, reinforcing once more our commitment to help your organizations implement Werfen’s strategy through our daily support and specialization.

With this reorganization, we are fully convinced to be prepared to face the future challenges and opportunities while continue being effective in our daily support to all of you. Please refer to the link below to see the latest CS Structure.

Org Support_EEMEAI_March2022

 

Customer Support Team EEMEAI

Last modified on Tuesday, 31 May 2022 14:04